You are here : Home / All Sectors / Healthcare / Pharmaceuticals & Drugs / IPCA LABORATORIES

IPCA LABORATORIES
Intrinsic Value | Fundamental Analysis

Returns | 1W : 0.2% , 1M : 14%,1Y : 44.8%
BOM : 524494     NSE : IPCALAB    
LT :  
    Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive]
Debt : Low
Updated:
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Neutral
Price Momentum : Upward
Pledged Shares : None or < 25%
Apr 20,2021
Price(EOD): Rs. 2,157.25
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
MarketCap: Rs. 27,375.50 Cr
Stock Market Investing Simplified- The best Video Course by Smart-Investing.in

Check out Industry Peers

Peers & Returns1W1M1Y
IPCA LABORATORIES 0.2% 14% 44.8%
SUN PHARMACEUTICAL INDUSTRIES 2.8% 10.2% 40.1%
DR REDDYS LABORATORIES 7.8% 18.3% 26.4%
DIVIS LABORATORIES 1.7% 12% 63.2%
CIPLA 7.2% 22.8% 58.3%
BIOCON -1.4% 3.4% 14.3%
AUROBINDO PHARMA 8.5% 17.7% 77.9%
LUPIN 5.1% 6.9% 28.9%
TORRENT PHARMACEUTICALS 1.5% 7.8% 15.5%

FUNDAMENTAL ANALYSIS OF IPCA LABORATORIES

 
Fundamentals Score
[Last Annual Data : Mar2020 | TTM
Trailing Twelve Months (TTM) is calculated using last 4 quarterly data and is a good substitute to track Annual results.
Learn More
]
Show Me the Stocks with Fundamentals better than IPCA LABORATORIES Premium


VALUATION OF IPCA LABORATORIES

 
Valuation Score
RatioValue
P/E
P/B
P/S
41.77
P/E Calculated based on EPS of 51.64
[ Mar2020 - Standalone Results ]

7.44
P/B Calculated based on Book Value of 290.11
[ Mar2020 - Standalone Results ]

5.65
P/S Calculated based on Revenues of 4841.67 Cr
[ TTM - Standalone Results ]

Show Me the Stocks with Valuation better than IPCA LABORATORIES Premium


FAIR VALUE OF IPCA LABORATORIES

 
Model Discount(-)/
Premium(+)
EV/EBIDTA
EV/Sales
Price/Sales
77%
111%
120%

SHARE PRICE MOMENTUM OF IPCA LABORATORIES

DEBT

Year Debt/Equity ratio
Standalone Consolidated
2020
2019
2018
Avg_3yrs
0.12
0.14
0.23
0.16
0.13
0.15
0.23
0.17
[Last Annual Data : Mar2020]

PLEDGED SHARES

Pledged Shares
0 %
As on : Sep2020

If less than 25%

Good
If between 25% and 50% Neutral
If greater than 50% Bad

QTRLY RESULTS

Standalone 1 Qtr Growth 4 Qtr Growth
Revenue
Op Profit
EBIDT
Net Income
1.34%
-2.85%
-3.62%
-5.7%
15.46%
28.76%
35.24%
32.21%
QtrlyTrend
2
Latest Qtr: Dec2020

IPCA LABORATORIES related INDICES

BSE Indices1W1M1Y
S&P BSE HEALTHCARE 4.4% 13% 55.2%
S&P BSE SMALLCAP SELECT INDEX 0.7% 1.3% 87%
S&P BSE SMALL CAP -0.1% 0.3% 91.4%
S&P BSE 150 MIDCAP -0.2% -0.2% 78.1%
S&P BSE MIDSMALLCAP -0.3% -0.3% 79.7%
S&P BSE 400 MIDSMALLCAP -0.4% -0.8% 81%
S&P BSE ALLCAP -1.1% -2.1% 60%
S&P BSE 250 LARGEMIDCAP -1.1% -2.2% 57.5%
S&P BSE 500 -1.1% -2.2% 59.1%
S&P BSE 200 -1.1% -2.2% 57.2%
NSE Indices1W1M1Y
NIFTY LARGE MIDCAP 250 0.5% -3.4% 72.3%
NIFTY MIDCAP150 -0.7% -0.9% 77%
NIFTY MID SMALL400 -0.7% -1% 81%
NIFTY FREE MIDCAP 100 -0.8% -0.5% 78.3%
NIFTY 500 -1.1% -2.2% 58.6%
NIFTY 200 -1.1% -2.2% 56.2%

FAQ [Frequently Asked Questions]


Is IPCALAB good for long term investment?

As on 20-Apr-2021, the Fundamentals of IPCALAB are Strong and hence it's good for long term investment! See Financial Performance of IPCA LABORATORIES . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!

Is IPCALAB UnderValued or OverValued?

As on 20-Apr-2021, IPCALAB is Over Valued and hence NOT a good buying opportunity according to Share Valuation at this time!

What is the Intrinsic Value of IPCALAB ?

As on 20-Apr-2021, the Intrinsic Value of IPCALAB is Rs. 1,022.73 determined based on Median of the 3 historical models.
Fair Value [Median EV / EBIDTA Model] : Rs. 1,215.88
Fair Value [Median EV / Sales Model] : Rs. 1,022.73
Fair Value [Median Price / Sales Model] : Rs. 980.54
Median Fair Value of IPCALAB : Rs. 1,022.73

Is IPCALAB trading at a Premium or Discount?

As on 20-Apr-2021, IPCALAB is trading at a Premium of 111% based on the Median Intrinsic Value!

Is it right time to buy IPCALAB shares?

As on 20-Apr-2021, IPCALAB is Over Valued and hence NOT a good buying opportunity according to Share Valuation at this time!

What is the Financial Performance of Industry Peers of IPCALAB?

Check out Financials of Industry Peers using below links:
Financials of SUN PHARMACEUTICAL INDUSTRIES LTD
Financials of DR REDDYS LABORATORIES LTD
Financials of DIVIS LABORATORIES LTD
Financials of CIPLA LTD
Financials of BIOCON LTD
Financials of AUROBINDO PHARMA LTD
Financials of LUPIN LTD
Financials of TORRENT PHARMACEUTICALS LTD
Financials of CADILA HEALTHCARE LTD
Financials of ABBOTT INDIA LTD

What are the Frequent Comparisons with IPCALAB?

IPCA LABORATORIES LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs DR REDDYS LABORATORIES LTD
IPCA LABORATORIES LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD
IPCA LABORATORIES LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD
IPCA LABORATORIES LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs BIOCON LTD
IPCA LABORATORIES LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs AUROBINDO PHARMA LTD
IPCA LABORATORIES LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs LUPIN LTD
IPCA LABORATORIES LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs TORRENT PHARMACEUTICALS LTD
IPCA LABORATORIES LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs CADILA HEALTHCARE LTD
IPCA LABORATORIES LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs ABBOTT INDIA LTD

Open Demat Account & Start Investing
    Affiliate Links

Disclosure

SEBI Research Analyst
The Founder of this website, Mr. Rohit Katiyar is registered with SEBI as a Research Analyst [INH000007377].


All Stocks : A - Z

ALL   A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z